Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Keizo Koya currently holds 12,999 shares of SYNTA PHARMACEUTICALS CORP (SNTA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Keizo Koya has been a net seller of SNTA stock. They have purchased $28.4K and sold $243.7K worth of shares.
Keizo Koya's most recent insider trade was on Mar 1, 2012, when they sold 6,844 shares at $4.70 per share.
Keizo Koya serves as Executive at SYNTA PHARMACEUTICALS CORP (SNTA). They have executed 7 insider transactions totaling $272.1K over their tenure at the company.
Keizo Koya holds the position of Executive at SYNTA PHARMACEUTICALS CORP, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Keizo Koya has shown a selling trading pattern, with $28.4K in total purchases and $243.7K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Keizo Koya was on Mar 1, 2011, when they sold $95.6K worth of SNTA shares. This transaction involved 18,270 shares at $5.23 per share.
Keizo Koya currently owns 12,999 shares of SYNTA PHARMACEUTICALS CORP (SNTA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Keizo Koya's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Keizo Koya has 7 Form 4 filings on record as an insider at SYNTA PHARMACEUTICALS CORP.
Set alerts for Keizo Koya and 40,000+ other insiders.